Engaging Patients. Virtual Trials. Enhanced Efficiency.

Transparency Life Sciences enables clinical trial sponsors to achieve higher quality outcomes while lowering overall costs. We currently offer two complementary service solutions: protocol crowdsourcing and digital “virtual” trial execution that eliminate or reduce the need for expensive, inconvenient patient site visits. We will soon be launching a digital phenotyping module that uses mobile health technology to understand and stratify the right patients for a clinical trial. All our offerings use proprietary software platforms that engage patients and other stakeholders to design and participate in more efficiently managed clinical trials. 

Clinical trial sponsors can partner with TLS for a broad range of business solutions ranging from open-innovation protocol design and digitization consulting through to full-scale clinical research services encompassing the design and execution of Phase I-IV clinical trials. We also channel partner with CROs to provide digitization services and tools that integrate, complement, and add efficiencies to sponsor projects.

We are building technology and service partnerships to make our service offerings fully integrated with the digital trials landscape. We are exploring partnerships and integrations in the following areas: telemedicine, mobile health, data management, online patient communities, document management, statistics, and remote diagnostics. 

By leveraging these TLS digital innovations, together we can transform every aspect of conducting clinical trials and the lives of those patients waiting for new medicines around the world.   

Contact us today for a project analysis and quote.

Case Study 1

Learn how TLS partnered with an investigational drug asset-holder to develop a fully digital protocol in a rare disease.

Case Study 2

Learn how TLS partnered with a large pharmaceutical company to design and execute a pilot study of telemedicine in the gastrointestinal space.

Always stay in the loop.
Sign up for our newsletter for the latest project updates.